4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: October 6, 2014
Period of Report: October 2, 2014
Accession Number: 0001178913-14-003121

View Document ↗ View on SEC.gov ↗